Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Diagnostic	1.88B
Diagnostic Growth	4.01%
Vaccine	606.43M
Vaccine Growth	-84.69%
Other Business	30.31M
Other Business Growth	75.20%
Inter-segment Eliminations	-273.57M
Inter-segment Eliminations Growth	-1.01%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	2.00B
China Growth	-62.58%
Overseas	215.93M
Overseas Growth	42.59%